CD274 and neoplasm: It stimulates the expression of PD-L1 on tumor and immune cells and induces adaptive mechanisms independent on PD-L1, e.g., epigenetic changes in tumor cells, which increase T cell inhibitory receptors (TCIR) expression [71,77].